Coincidence of 3-methylglutaconic aciduria and duplication 5q - a case report and literature review.


Journal

Acta biochimica Polonica
ISSN: 1734-154X
Titre abrégé: Acta Biochim Pol
Pays: Poland
ID NLM: 14520300R

Informations de publication

Date de publication:
08 Jun 2020
Historique:
received: 24 04 2020
accepted: 11 05 2020
pubmed: 9 6 2020
medline: 20 2 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

3-methylglutaconic aciduria includes a heterogeneous group of inborn errors of metabolism. The disease may have various clinical presentations, as can duplication 5q. We present the case of a 13-year-old boy with 3-methylglutaconic aciduria and duplication 5q. The main symptoms included myopathy, weakness, spastic paresis intensified mostly in the lower limbs, and intellectual disability. Additional studies showed elevated levels of 3-methylglutaconic acid in urine and ammonia in plasma. A duplication in region 5q23.3q31.1 was found in array-based comparative genomic hybridization. Next-generation sequencing did not reveal any pathological mutation. On the basis of the clinical picture and the results of biochemical and genetic tests 3-methylglutaconic aciduria type IV with duplication 5q was diagnosed.

Identifiants

pubmed: 32511901
pii: 5355
doi: 10.18388/abp.2020_5355
doi:

Substances chimiques

Glutarates 0
3-methylglutaconic acid 5746-90-7
Ammonia 7664-41-7

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

263-266

Auteurs

Paweł Zapolnik (P)

Students' Scientific Association of Clinical Genetics, Department of Clinical Genetics, Medical College, University of Rzeszów, Poland.

Jolanta Sykut-Cegielska (J)

Department of Inborn Errors of Metabolism and Paediatrics, Institute of Mother and Child, Warsaw, Poland.

Antoni Pyrkosz (A)

Department of Clinical Genetics, Medical College, University of Rzeszów, Rzeszów, Poland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH